eosinophilic gastroenteritis ege epidemiology forecast insight

DelveInsight’s ‘Eosinophilic Gastroenteritis (EGE) – Epidemiology Forecast—2034’ report delivers an in-depth understanding of Eosinophilic Gastroenteritis (EGE) historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geographies Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2021-2034

Eosinophilic Gastroenteritis (EGE) Disease Understanding

Eosinophilic Gastroenteritis (EGE) is a rare digestive disease characterized by the triad of eosinophilic infiltration of segments of the gastrointestinal tract, abnormalities of gastrointestinal function (varying from dyspepsia and obstruction to diarrhea and ascites), and exclusion of other diseases with peripheral eosinophilia.

Eosinophilic Gastroenteritis (EGE) Epidemiology

The Eosinophilic Gastroenteritis (EGE) epidemiology division provides insights about the historical and current patient pool, along with the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed patient pool, trends, and assumptions.

Key Findings

The total prevalent cases of Eosinophilic Gastroenteritis (EGE) patients are increasing in 7MM during the study period, i.e., 2021-2034.

The disease epidemiology covered in the report provides historical as well as forecasted Eosinophilic Gastroenteritis (EGE) symptoms epidemiology segmented as the Prevalence of Eosinophilic Gastroenteritis, Gender-specific cases of Eosinophilic Gastroenteritis, and Age-specific Cases of Eosinophilic Gastroenteritis. The report includes the prevalent scenario of Eosinophilic Gastroenteritis (EGE) symptoms in 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2021 to 2034.

Country-wise Eosinophilic Gastroenteritis (EGE) Epidemiology

The epidemiology segment also provides the Eosinophilic Gastroenteritis (EGE) epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

• The prevalent cases of Eosinophilic Gastroenteritis (EGE) associated in 7MM countries were 58,560 in 2020.
• As per the estimates, the United States has the largest prevalent population of Eosinophilic Gastroenteritis (EGE)
• Among the EU5 countries, Germany had the highest prevalent cases of Eosinophilic Gastroenteritis (EGE), followed by France. On the other hand, Spain had the lowest prevalent cases with 2,695 cases in 2020.

Scope of the Report

• The Eosinophilic Gastroenteritis (EGE) report covers a detailed overview explaining its causes, symptoms, and classification, pathophysiology, diagnosis, and treatment patterns.
• The Eosinophilic Gastroenteritis (EGE) Epidemiology Report and Model provide an overview of Eosinophilic Gastroenteritis (EGE) ’s risk factors and global trends in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
• The report provides insight into Eosinophilic Gastroenteritis (EGE)’s historical and forecasted patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.
• The report helps to recognize the growth opportunities in the 7MM concerning the patient population.
• The report assesses the disease risk and burden and highlights the unmet needs of Eosinophilic Gastroenteritis (EGE).
• The report provides the segmentation of the Eosinophilic Gastroenteritis (EGE) epidemiology by the prevalence of Eosinophilic Gastroenteritis (EGE) in 7MM.
• The report provides the Eosinophilic Gastroenteritis (EGE) epidemiology segmentation by Gender-specific cases of Eosinophilic Gastroenteritis (EGE) in 7MM.
• The report provides the Eosinophilic Gastroenteritis (EGE) epidemiology segmentation by Age-specific Cases of Eosinophilic Gastroenteritis (EGE) in 7MM.

Report Highlights

• 10-year Forecast of Eosinophilic Gastroenteritis (EGE) epidemiology
• 7MM Coverage
• Prevalence of Eosinophilic Gastroenteritis (EGE)
• Gender-specific cases of Eosinophilic Gastroenteritis (EGE)
• Age-specific Cases of Eosinophilic Gastroenteritis (EGE)

KOL Views

We interview KOLs, and SMEs’ opinions through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

• What are the major factors that will drive the change in patient population in Eosinophilic Gastroenteritis (EGE) during the forecast period (2021-2034)?
• What are the key findings of the Eosinophilic Gastroenteritis (EGE) epidemiology across 7MM, and which country will have the highest number of patients during the forecast period (2021-2034)?
• What would be the total number of Eosinophilic Gastroenteritis (EGE) patients across the 7MM during the forecast period (2021-2034)?
• Among the EU5 countries, which country will have the highest number of patients during the forecast period (2021-2034)?
• At what CAGR the patient population is expected to grow in 7MM during the forecast period (2021-2034)?
• What are the disease risk, burden, and unmet needs of Eosinophilic Gastroenteritis (EGE)?
• What are the currently available treatments for Eosinophilic Gastroenteritis (EGE)?

Reasons to buy

The Eosinophilic Gastroenteritis (EGE) epidemiology report will allow the user to -

• Develop business strategies by understanding the trends shaping and driving the global Eosinophilic Gastroenteritis (EGE) market.
• Quantify patient populations in the global Eosinophilic Gastroenteritis (EGE) market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Eosinophilic Gastroenteritis (EGE) therapeutics in each market covered.
• Understand the magnitude of the Eosinophilic Gastroenteritis (EGE) population by its prevalence.
• Understand the magnitude of the Eosinophilic Gastroenteritis (EGE) population by its Gender-specific cases.
• Understand the magnitude of the Eosinophilic Gastroenteritis (EGE) population by its Age-specific cases.
• The Eosinophilic Gastroenteritis (EGE) epidemiology report and model were written and developed by Masters and PhD level epidemiologists.
• The Eosinophilic Gastroenteritis (EGE) Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.

Key Assessments

• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population